Uveal melanoma is a rare but serious form of eye cancer that arises from the melanocytes in the uveal tract, which includes the iris, ciliary body, and choroid. Although it accounts for a small percentage of all melanomas, uveal melanoma is the most common primary intraocular malignancy in adults. Early detection and treatment are crucial to prevent vision loss and reduce the risk of metastasis, particularly to the liver. The management of uveal melanoma depends on tumor size, location, the patient’s overall health, and potential impact on vision. Treatment approaches range from careful observation for small lesions to radiotherapy, laser therapy, or surgical interventions for larger or high-risk tumors.
Understanding Uveal Melanoma
The uveal tract is highly vascular, which allows tumors in this region to potentially spread to other parts of the body. Uveal melanoma can develop in any part of the uvea, but the choroid is the most common site. Risk factors include fair skin, light eye color, genetic predispositions, and certain ocular conditions. Symptoms may be subtle at first, including visual disturbances, blurred vision, or the appearance of floaters, making routine eye exams essential for early detection.
Causes and Risk Factors
- Genetic mutations, particularly in the GNAQ, GNA11, and BAP1 genes
- Light-colored eyes and fair skin, which may be more sensitive to UV exposure
- Age, with most cases diagnosed in adults over 50
- Pre-existing conditions such as ocular melanocytosis or dysplastic nevus syndrome
Diagnosis
Accurate diagnosis of uveal melanoma requires a combination of clinical examination and imaging studies. Early detection improves the chances of preserving vision and reduces the likelihood of metastasis.
Ophthalmic Examination
Comprehensive eye exams with dilated pupils allow ophthalmologists to observe the uveal tract directly. Suspicious lesions are noted for size, shape, pigmentation, and growth patterns.
Imaging Studies
- Ultrasound Provides detailed measurements of tumor thickness and size.
- Fluorescein angiography Assesses blood flow within the tumor.
- Optical coherence tomography (OCT) Visualizes the retina and choroid layers for subtle changes.
- MRI or CT scans Evaluate larger tumors and detect potential metastasis, especially to the liver.
Biopsy
In some cases, fine-needle aspiration biopsy may be performed to confirm the diagnosis and assess genetic markers that indicate metastatic risk. Genetic profiling helps guide treatment decisions and long-term monitoring.
Treatment Options for Uveal Melanoma
Treatment strategies depend on tumor size, location, risk of metastasis, and the goal of preserving vision. Management is typically individualized to balance effectiveness with quality of life.
Observation
For small, low-risk tumors that show minimal growth, close monitoring may be recommended. Regular eye exams and imaging are used to track changes in tumor size or behavior. Observation avoids unnecessary interventions and potential side effects while still allowing timely action if the tumor progresses.
Radiation Therapy
Radiotherapy is a primary treatment for many uveal melanomas, particularly those located in the choroid or ciliary body.
- Plaque brachytherapy A small radioactive plaque is temporarily placed on the outside of the eye directly over the tumor to deliver focused radiation.
- Proton beam therapy Provides precise radiation that minimizes damage to surrounding healthy tissues, suitable for larger or more complex tumors.
Laser Therapy
Laser treatments can be used for small tumors or as an adjunct to radiotherapy. Techniques such as transpupillary thermotherapy (TTT) use heat to destroy tumor cells without removing the eye, making it an eye-preserving option for selected patients.
Surgical Options
Surgery is considered when radiation is not suitable or for larger tumors that threaten vision.
- Local resection Removal of the tumor while preserving as much of the eye as possible.
- Enucleation Complete removal of the eye, generally reserved for large or aggressive tumors where other treatments cannot control the disease.
- Orbital exenteration Rarely needed, involves removing the eye and surrounding tissues in extensive cases.
Systemic Considerations
Uveal melanoma has a high risk of metastasis, particularly to the liver. Treatment planning often includes systemic evaluation to detect early spread and tailor follow-up care.
Liver Monitoring
Regular liver function tests and imaging, including ultrasound, MRI, or CT scans, help detect metastasis early. Early intervention may include surgical removal of liver lesions or systemic therapies to manage metastatic disease.
Targeted and Immunotherapy
For metastatic or high-risk cases, emerging treatments include targeted therapies based on genetic mutations and immunotherapies that stimulate the immune system to attack tumor cells. Clinical trials may provide access to innovative therapies not widely available.
Post-Treatment Care
After treatment, careful follow-up is essential to monitor for recurrence, manage side effects, and preserve vision and quality of life.
Regular Eye Exams
Follow-up visits with ophthalmologists and oncologists ensure that any new growth or complications are detected early. Imaging and vision assessments are conducted at scheduled intervals.
Vision Rehabilitation
For patients experiencing vision changes, rehabilitation may include visual aids, occupational therapy, or support for adjusting daily activities to maintain independence and quality of life.
Psychological Support
Being diagnosed with uveal melanoma can be emotionally challenging. Counseling or support groups help patients cope with stress, anxiety, and adjustment to changes in vision or lifestyle.
Prognosis
Prognosis depends on tumor size, location, genetic features, and presence of metastasis. Early detection and treatment increase the likelihood of preserving vision and reducing the risk of spread. Genetic profiling provides important information about metastatic potential and guides follow-up care. While localized uveal melanoma can often be managed successfully, regular monitoring is essential due to the risk of delayed metastasis.
Treatment for uveal melanoma requires a comprehensive, individualized approach that balances tumor control with preservation of vision. Options include careful observation, radiotherapy, laser therapy, and surgical interventions, depending on tumor characteristics and patient needs. Systemic evaluation and ongoing monitoring for liver metastasis are essential components of care. Advances in genetic profiling, targeted therapy, and immunotherapy offer new hope for patients with high-risk or metastatic disease. With timely diagnosis, appropriate treatment, and long-term follow-up, patients with uveal melanoma can achieve optimal outcomes, maintain vision when possible, and reduce the risk of disease progression.